Symbols

IRTC

iRhythm·NASDAQ

--(--)

Signals Analysis

Bullish signal 5

Bearish signal 0

Consensus Rating "Buy"

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About IRTC

Irhythm Holdings, Inc.

A leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease

Industry

Healthcare Technology

Established Date

09/14/2006

Listing Date

10/20/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

2,400

Fiscal Year Ends

12-31

Website

www.irhythmtech.com

Security Type

Common stock

Office address

699 8th Street, Suite 600, San Francisco, California 94103

Business

Introduction

IRhythm Holdings, Inc., was incorporated in Delaware on September 14, 2006. IRhythm is a leading digital healthcare company dedicated to building trusted solutions for detecting, predicting and preventing disease. Its main business is the design, development and commercialization of device-based dynamic cardiac monitoring technology. IRhythm believes that these technologies can help clinicians diagnose certain arrhythmias faster and more efficiently than other services that rely on traditional technologies.

Company Financials

EPS

IRTC has released its 2025 Q4 earnings. EPS was reported at 0.17, versus the expected 0.01, beating expectations. The chart below visualizes how IRTC has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

IRTC has released its 2025 Q4 earnings report, with revenue of 208.89M, reflecting a YoY change of 27.12%, and net profit of 5.58M, showing a YoY change of 518.53%. The Sankey diagram below clearly presents IRTC's revenue sources and cost distribution.